Old Web
English
Sign In
Acemap
>
authorDetail
>
Santosh M. Nair
Santosh M. Nair
Medicine
Internal medicine
Birinapant
Inhibitor of apoptosis
Immune system
3
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nanatinostat (Nstat) and Valganciclovir (VGCV) in Relapsed/Refractory (R/R) Epstein-Barr Virus-Positive (EBV + ) Lymphomas: Final Results from the Phase 1b/2 VT3996-201 Study
2021
Blood
Bradley M. Haverkos
Onder Alpdogan
Robert A. Baiocchi
Jonathan E. Brammer
Tatyana Feldman
Marcelo Capra
Elizabeth Brem
Santosh M. Nair
Phillip Scheinberg
Juliana Pereira
Leyla Shune
Erel Joffe
Afton Katkov
Robert McRae
Ivor Royston
Lisa Rojkjaer
Pierluigi Porcu
Show All
Source
Cite
Save
Citations (0)
Pharmacokinetics/Pharmacodynamics, Safety and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease and a History of Vaso-Occlusive Crises: Results from the Phase II, Multicenter, Open-Label Solace-Adults Study
2020
Blood
Darla K. Liles
Kim Smith-Whitley
R. Clark Brown
Nirmish Shah
Santosh M. Nair
Chiaki Tanaka
Shankaranand Bodla
Gessami Sanchez-Olle
Urs Albers
Julie Kanter
Show All
Source
Cite
Save
Citations (1)
A phase 1/2 study with birinapant in combination with pembrolizumab.
2018
Journal of Clinical Oncology
Russell J. Schilder
Mark Albertella
James Strauss
Malin Sydvander
Santosh M. Nair
Kingsley Urakpo
Stefan Norin
John F. Öhd
Show All
Source
Cite
Save
Citations (3)
1